eli lilly and company was founded in indianapolis indiana. on may 10, just last saturday, lily celebrated its 138th birthday as a u.s. company. our mission is t to discover and develop medicines that help people live longer, healthier or active lives. our major areas include therapy for cancer, diabetes and mental illnesses. to fulfill this vision will we must rely on patents, trademarks and trade secrets. unfortunately like too many of america's firms lily has been the victim of trade secret theft. lilly is a member of the coalition across the sector a group of companies that can separate the harmonized federal civil this appropriation. we are pleased to support the defendant trade secrets act s. 2267 that would've published this objective and we thank the senators for their leadership and we are also encouraged by your work, chairman white house and ranking member to ensure law-enforcement has the tools it needs. by the committee's work is important to the shared objective i and improving the effectiveness of efficiency to the trade secret

. >> reporter: dave ricks leads the unit at eli lilly. he says much of the focus is medicine for the ageing, a shift from the past. >> the science and study of diseases of the elderly has, in fact, increased and therefore our about thety to look for medicines in that space have coincided with this underlying market demand in the elderly ageing population. >> reporter: one area remains particularly challenging, alzheimer's disease. the medicines currently on the market address just the symptoms rather than underlying cause and the industry seen several high-profile failures. still, they continue to work in the space. the number of medicines in development tripled from a decade ago as more than 36 million people world wide have dementia, a number expected to grow without intervention. the swelling number of seniors will put pressure on health care costs. the number of beneficiaries is expected to rise to 52 million to 80 million and costs are expected to rise from 3.5% of gdp now to 5.6% in 2040. for "nightly business report", i'm meg terre

pfizer,anies are novartis, eli lilly. they're trying to improve and extend human lives.ecific mission. toare helping them do that, help them develop drugs faster, bring them to market more effectively. transform trying to the industry. a specific industry. >> this demonstrates the notion of how the software industry works. i've covered this for a long time. 28% of all software sales, that is eager than the database market. much bigger than the operating system market. what has the trend been there? >> what is happening is that it has been the case but it is accelerating. isustry specific software big as the as -- market. with cloud software, you can tackle these industry-specific problems more effectively, you can use the use of that to generate data. it is accelerating the value of industries. that we have for running custom software for their auto plants anymore. will we see more than the future, not less? custom are writing software, that was not even included. going forward, we will see less custom software. our customers are developing less custom software because t

our companies are pfizer, novartis, eli lilly.delivering cloud solutions to help them with their most critical problems. these companies are trying to improve and extend human lives. a very specific mission. we are helping them do that, to help them develop drugs faster, bring them to market more effectively. so, we are trying to transform the industry. a specific industry. >> i saw a study that demonstrated the notion of how the software industry works. i covered this for a long time, but it blew my mind, the specificity. industry-specific software is 20% of all software sales. i was amazed by that. bigger than the database market. massively. much bigger than the operating system market. has this always been the case? what has the trend been there? >> you know, what is happening, it has been the case, but it is accelerating. here is a point i tell people. industry specific software is four times as big as the e.r.p. market. with cloud software, you can tackle these industry-specific problems more effectively, you can use the use

wanted to pull up pharmaceuticals because every name we're looking at -- not just pfizer, merck, eli lillylso have a lot of these names, merck is down, abbott labs, wristal meyers -- bristol-myers, it is just part and parcel of what's happening with the markets, although we are coming up off the lowsover the stress. at one point the dow was down 200 points, right now the s&p down 17, and the dow jones industrials coming well off the lows down about 127. >>> hashtag tbt. you know it's throwback thursday, which we hope you do, because when -- tuesday, which we hope you do. in today's fit for business series, we're channeling our own '70s and '80s spirits from remember that? forget about being picked last for the team, we're going to make this fun for you as we continue to look at some of the most innovative and profitable companies in the fitness industry. throwback is innovating the boutique fitness world by getting inspiration from the days of yore. co-founders brian gallagher and ryan willkie are here to help whip us into shape by reliving what our childhood phys ed classes? >> that is ri